Herpes simplex virus type 1 (HSV-1) plasmid vectors have promise for genetic intervention
in the brain, but several problems caused by the helper virus have compromised their utility. …

Background Tick-borne encephalitis (TBE) is increasing in Europe. We aimed to evaluate
the immunogenicity and safety of TBE-vaccination. Methods This systematic review was …

Objective Understanding the factors that influence human papillomavirus (HPV) vaccination
uptake is critically important to the design of effective vaccination programmes. In …

… request, without undue reservation, by contacting the study authors (phung.lang@uzh.ch). …
on request, without undue reservation, by contacting the study authors (phung.lang@uzh.ch). …

Background Overall incidence and geographic range of Tick-borne Encephalitis (TBE), a
vaccine preventable infection, have steadily increased in Switzerland over the last 50 years. …

Background and objective Seasonal influenza may cause serious illness, especially in high-risk
populations such as older adults and individuals suffering from non-communicable …

Objectives. We described the results from the Swiss National Vaccination Coverage Survey (SNVCS)
2005–2007, a survey designed to monitor immunization coverage of children and …

Streptococcus pneumoniae, or pneumococcus, is a common, opportunistic pathogen which
can cause severe disease, particularly in adults 65+. In Switzerland, vaccination is …

A defective herpes simplex virus type one (HSV‐1) vector that contains a 6.8‐kb fragment of
the rat tyrosine hydroxylase promoter (pTHlac‐7kb) was examined for its capability to target …

Tick-borne Encephalitis (TBE) is a severe disease of the Central Nervous System (CNS)
caused by the tick-borne encephalitis virus (TBEV). The generation of protective immunity after …